0.82 USD
▲+0.09+3.98%
盘后 0.78 -1.95%
2026-08-03
市值
$5.47M
市盈率
—
EPS
-4.77
股息率
—
52 周区间
0.62 – 13.00
成交量
143.39K
Beta
1.22
目标价
13.50
52W 低 0.6252W 高 13.00
价格走势
公司简介
FibroBiologics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of fibroblast-based therapies for patients suffering from chronic diseases. The company’s product pipeline includes CYWC628 which has completed pre-clinical trial for the treatment of wound healing; CYMS101 which has completed Phase 1 trial for the treatment of multiple sclerosis; CybroCell for the treatment of degenerative disc disease; and CYPS317 for the treatment of psoriasis. It also develops early-stage research products, includi...